3/27
07:55 am
howl
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates [Yahoo! Finance]
Medium
Report
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates [Yahoo! Finance]
3/27
07:00 am
howl
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
Medium
Report
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
2/24
04:09 pm
howl
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
High
Report
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
1/23
05:09 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Werewolf Therapeutics (NASDAQ:HOWL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/12
04:46 am
howl
Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results [Yahoo! Finance]
Medium
Report
Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results [Yahoo! Finance]